title: Contrast enhancement in progressive multifocal leukoencephalopathy: a predictive factor for long-term survival?
authors.forename: V
authors.initials: V
authors.lastname: Arbusow
authors.forename: M
authors.initials: M
authors.lastname: Strupp
authors.forename: H W
authors.initials: HW
authors.lastname: Pfister
authors.forename: K C
authors.initials: KC
authors.lastname: Seelos
authors.forename: H
authors.initials: H
authors.lastname: Brückmann
authors.forename: T
authors.initials: T
authors.lastname: Brandt
mesh_terms: D000368:Aged; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007577:JC Virus / Q000502:physiology; D007968:Leukoencephalopathy, Progressive Multifocal / Q000473:pathology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D011237:Predictive Value of Tests; D011379:Prognosis; D015996:Survival Rate
chemical_list: D007166:Immunosuppressive Agents